Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

BACKGROUND: Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma have iden...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Tsai, Harrison K., Lehrer, Jonathan, Alshalalfa, Mohammed, Erho, Nicholas, Davicioni, Elai, Lotan, Tamara L.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5683385/
https://ncbi.nlm.nih.gov/pubmed/29132337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3729-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki